A prominent cardiovascular health researcher at UK whose work is internationally recognized in the field of vascular biology, has been honored for her groundbreaking work by the American Heart Association.
In its inaugural year, the Lighthouse Beacon Foundation Endowment has made $160,000 in funds available for distribution, with a priority on research support.
American Heart Association CEO, Nancy Brown, highlighted the historic collaboration between the AHA and UK during her featured presentation at the annual event.
The REBIRTH trial is hoping to provide the definitive answer as to whether bromocriptine has additional benefits to women in addition to standard medical therapy. UK is one of 50 centers across the country participating in REBIRTH.
